1.0Market Snapshot
- CHF 2.3B
- Health spending on medical laboratories in 2024 (CHF 2,308 million), of which CHF 799 million was paid by basic health insurance — BFS health costs by provider. It was CHF 2,470 million in 2021, at the height of COVID-19 testing. Hospital laboratories are counted with the hospitals.
- 186
- Enterprises classified as medical laboratories (NOGA 86.90.06) in 2024, BFS STATENT. Laboratories inside hospitals are counted with the hospitals.
- 8,134
- Employees of medical laboratories in 2024 (6,549 full-time equivalents), BFS STATENT. The peak was 8,559 in 2021, during COVID-19 testing; 70.5% are women.
- +3.2%
- Average annual employment growth of medical laboratories from 2011 (5,370) to 2024 (8,134), BFS STATENT. Since the 2021 peak employment has fallen slightly (−0.4% in 2024).
According to Val Index analysis of Swiss commercial-register and federal data (2026), the Swiss laboratory & diagnostics market is worth CHF 2.3B — Health spending on medical laboratories in 2024 (CHF 2,308 million), of which CHF 799 million was paid by basic health insurance — BFS health costs by provider. It was CHF 2,470 million in 2021, at the height of COVID-19 testing. Hospital laboratories are counted with the hospitals..
According to Val Index analysis of Swiss commercial-register and federal data (2026), Switzerland counts 186 laboratory & diagnostics companies — Enterprises classified as medical laboratories (NOGA 86.90.06) in 2024, BFS STATENT. Laboratories inside hospitals are counted with the hospitals..
2.0Industry Overview
Switzerland had 186 private medical laboratories with 8,134 employees in 2024, according to BFS business statistics (STATENT); hospital laboratories are counted separately with the hospitals. Employment grew by more than half from 2011 to 2021, peaked at 8,559 during COVID-19 testing and has eased slightly since. Laboratories are large units by healthcare standards — 35 full-time equivalents on average — because testing is automated and concentrated in central laboratories supplied by courier networks from doctors' practices across the country.
3.0Industry Health Check (SWOT)
- Steady demand from an ageing population and more outpatient diagnostics
- Prices are set by the federal analysis list, not by the market
- Consolidation of smaller regional laboratories by the large groups
- Further tariff cuts through the revision of all ~1,300 analysis positions (transAL)→ §4.0
Unlock full Laboratory & Diagnostics intelligence
Market trends, cost structure, key players, succession analysis and regional clusters for Laboratory & Diagnostics — subscribe free to Market Pulse.
Free weekly newsletter. Unsubscribe anytime.
8.0Regional Clusters
Western Switzerland
65 laboratories with 3,526 employees in 2024 — 43% of the national total. Vaud (1,468) and Geneva (1,303) are the two largest cantons by laboratory employment.
Zurich
37 laboratories with 1,215 employees, the most laboratories of any canton.
Eastern Switzerland
10 laboratories with 899 employees, most of them in St. Gallen (797), where Labor Team runs its central laboratory in Goldach.
Northwestern Switzerland
19 laboratories with 892 employees; Basel-Landschaft has 715 of them, mainly at Viollier in Allschwil.
Central Switzerland
15 laboratories with at least 781 employees; Lucerne alone has 751 in 4 laboratories (Schwyz figures are suppressed by BFS).
Bern and Solothurn
22 laboratories with 730 employees.
Ticino
9 laboratories with 84 employees. Canton figures sum to slightly less than the national total because BFS suppresses small cells.
Sources
Corrections
Figures and statements from the February 2026 edition that this edition withdraws or corrects, and why.
- "CHF 3-4B market" withdrawn: no source. BFS health-cost statistics put spending on medical laboratories at CHF 2.3 billion in 2024.
- "~500 laboratories" and "~12,000 employees" replaced by BFS STATENT 2024: 186 laboratories and 8,134 employees.
- "~10% export ratio", "+6% growth (FAMH 2025)" and "~85% accreditation rate" withdrawn: no source.
- Synlab Suisse removed as a separate player: it was sold to Sonic Healthcare in 2023.
- Unilabs corrected: owned by A.P. Moller Holding (not "AP Moller Capital") and registered in Coppet (VD), not Dübendorf (ZH).
- "MCL Medizinische Laboratorien" removed: no entry under that name in the commercial register.
- "Viollier ~1,200 employees" withdrawn: not published by the company.
- The cost split is now labelled as indicative: it was never measured.
9.0Frequently Asked Questions
▶How much is a medical laboratory worth in Switzerland?
ValIndex's multiples table puts Swiss laboratory services at 7.0–10.0× EBITDA in transactions and 5.5–7.5× EBITDA on statutory valuations. The EBITDA must reflect the tariffs in force from July 2026 and the end of fee-for-service payments to doctors; results from the COVID-19 testing years 2020–2022 are not a guide. Specialised and well-automated laboratories reach the upper end.
▶What drives the value of a Swiss medical laboratory?
Buyers price: (1) volume and the mix of analyses under the federal analysis list; (2) exposure to the ten highest-revenue analyses cut in July 2026; (3) referring-doctor relationships; (4) automation and cost per test; (5) accreditation and specialised tests (genetics, pathology, microbiology); (6) courier coverage and location.
▶How big is the Swiss medical laboratory market?
BFS STATENT counts 186 private medical laboratories with 8,134 employees in 2024. BFS health-cost statistics put spending on medical laboratories at CHF 2,308 million in 2024 (CHF 2,470 million in 2021, during COVID-19 testing), of which CHF 799 million was paid by basic health insurance. Galenica puts Labor Team's share of the private-laboratory market at about 8%.
▶Who owns Switzerland's medical laboratories?
The largest groups are Sonic Healthcare of Australia (Sonic Suisse, built on Medisupport and Synlab Suisse), Unilabs (owned by the Maersk family's A.P. Moller Holding since 2022), the independent family company Viollier (founded 1953) and Galenica, which bought Labor Team in September 2025.
▶What are the key trends for Swiss medical laboratories?
Five trends: (1) tariff cuts from July 2026 worth about CHF 85 million a year, with a full tariff revision (transAL) to follow; (2) consolidation by groups — Sonic, Unilabs, Galenica; (3) normalisation after the COVID-19 peak of 8,559 employees in 2021; (4) diagnostics moving into pharmacies; (5) the remaining independent regional laboratories becoming targets.
▶What are the main risks when buying a Swiss laboratory?
The main risks are: (1) further tariff cuts under transAL; (2) loss of referring doctors after the end of fee-for-service payments; (3) competition authority review in concentrated regional markets; (4) shortage of biomedical analysts; (5) dependence on a few specialists. Due diligence should model revenue at the new tariffs and check accreditation and referral contracts.
▶How do the July 2026 tariff cuts affect laboratories?
From July 2026 the order fee fell by CHF 5, the ten highest-revenue analyses were cut by 10–20%, and laboratories no longer pay "fees for service" to referring doctors. The BAG expects savings of about CHF 85 million a year for basic health insurance. Laboratories with a high share of routine analyses are hit hardest; the revision of all ~1,300 tariff positions will follow.
▶Where are Swiss medical laboratories located?
Western Switzerland has 43% of laboratory employment (3,526 employees in 65 laboratories in 2024), led by Vaud and Geneva. Zurich has the most laboratories (37, with 1,215 employees). Large central laboratories sit in St. Gallen (797 employees, Labor Team in Goldach), Basel-Landschaft (715, Viollier in Allschwil) and Lucerne (751, Sonic Suisse).